Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Getts

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Trends in Immunology|June 20, 2015
Harnessing nanoparticles for immune modulationDaniel R Getts, Lonnie D Shea, Stephen D Miller, et al.
Trends in Immunology|September 12, 2016
Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016)Daniel R Getts, Lonnie D Shea, Stephen D Miller, et al.
Immunotherapy|January 7, 2020
Implications of T cell receptor biology on the development of new T cell therapies for cancerIan R Hardy, Wolfgang W Schamel, Patrick A Baeuerle, et al.
Pharmaceutics|November 11, 2022
Immune Modifying Effect of Drug Free Biodegradable Nanoparticles on Disease Course of Experimental Autoimmune NeuritisEhsan Elahi, Mohamed Ehab Ali, Julian Zimmermann, et al.
Communications Biology|December 20, 2018
Experimental severe malaria is resolved by targeting newly-identified monocyte subsets using immune-modifying particles combined with artesunatePaula Niewold, Amy Cohen, Caryn van Vreden, et al.
Mabs|October 12, 2010
Have we overestimated the benefit of human(ized) antibodies?Daniel R Getts, Meghann T Getts, Derrick P McCarthy, et al.
Immunology and Cell Biology|December 6, 2006
Immunopathology of flavivirus infectionsNicholas J C King, Daniel R Getts, Meghann T Getts, et al.
Journal of Autoimmunity|December 21, 2017
Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cellsSuchitra Prasad, Tobias Neef, Dan Xu, et al.
Journal of Neuroinflammation|December 19, 2012
Inflammatory monocytes and the pathogenesis of viral encephalitisRachael L Terry, Daniel R Getts, Celine Deffrasnes, et al.
Immunotherapy|July 15, 2011
Current landscape for T-cell targeting in autoimmunity and transplantationDaniel R Getts, Sushma Shankar, Emily M L Chastain, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Trends in Immunology|June 20, 2015
Harnessing nanoparticles for immune modulationDaniel R Getts, Lonnie D Shea, Stephen D Miller, et al.
Trends in Immunology|September 12, 2016
Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016)Daniel R Getts, Lonnie D Shea, Stephen D Miller, et al.
Immunotherapy|January 7, 2020
Implications of T cell receptor biology on the development of new T cell therapies for cancerIan R Hardy, Wolfgang W Schamel, Patrick A Baeuerle, et al.
Pharmaceutics|November 11, 2022
Immune Modifying Effect of Drug Free Biodegradable Nanoparticles on Disease Course of Experimental Autoimmune NeuritisEhsan Elahi, Mohamed Ehab Ali, Julian Zimmermann, et al.
Communications Biology|December 20, 2018
Experimental severe malaria is resolved by targeting newly-identified monocyte subsets using immune-modifying particles combined with artesunatePaula Niewold, Amy Cohen, Caryn van Vreden, et al.
Mabs|October 12, 2010
Have we overestimated the benefit of human(ized) antibodies?Daniel R Getts, Meghann T Getts, Derrick P McCarthy, et al.
Immunology and Cell Biology|December 6, 2006
Immunopathology of flavivirus infectionsNicholas J C King, Daniel R Getts, Meghann T Getts, et al.
Journal of Autoimmunity|December 21, 2017
Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cellsSuchitra Prasad, Tobias Neef, Dan Xu, et al.
Journal of Neuroinflammation|December 19, 2012
Inflammatory monocytes and the pathogenesis of viral encephalitisRachael L Terry, Daniel R Getts, Celine Deffrasnes, et al.
Immunotherapy|July 15, 2011
Current landscape for T-cell targeting in autoimmunity and transplantationDaniel R Getts, Sushma Shankar, Emily M L Chastain, et al.
Pageof 5